腹腔镜辅助子宫肌瘤剔除术30例手术体会

目的：观察腹腔镜辅助子宫肌瘤剔除术的疗效,探讨腹腔镜辅助子宫肌瘤剔除术的可行性。方法：回顾性分析我院2008年全年30例子宫肌瘤患者的手术方法及手术结果。结果：30例患者全部治愈,平均手术时间78min,术后患者指征数据佳。结论：腹腔镜辅助子宫肌瘤剔除术综合了经典开腹及微创手术的优点,可以提倡。     

8年间剖宫产率及指证变化的临床分析

近年来，我国各地的剖宫产率均呈明显的上升趋势，部分地区的剖宫产率甚至高达60％。居高不下的剖宫产率已引起了广大产科工作者和全社会的广泛关注。对我院近8年来剖宫产病例的临床资料进行回顾性分析，以寻求剖宫产率逐年上升的原因及探讨降低剖宫产率的途径与方法。     

CT影像学评分预测急性胰腺炎病情及转归的研究

目的 探讨CT影像学评分对急性胰腺炎病情和转归的预测价值。方法 回顾性分析入院后经CT检查的急性胰腺炎46例，按一定的规则对每例患进行CT影像学评分与分型，并与临床治疗中的有关资料进行对照。结果 46例患CT评分后获得：轻型24例，中型13例，重型9例。轻型患较重型住院日少、恢复顺利，中转手术及死亡率均以重型为高。结论 CT评分对急性胰腺炎病情及预后评估具有重要意义。     

褪黑素对大鼠脑缺血再灌注损伤及胞浆型磷脂酶A_2蛋白表达的影响

目的观察褪黑素在脑损伤时对脑细胞凋亡和胞浆型磷脂酶A2(cPLA2)蛋白的表达及相关介质的影响。方法采用线栓法制作大脑中动脉缺血再灌注模型,将78只雄性Wister大鼠随机分为假手术组(6只)、模型组(36只)、治疗组(36只)。用HE染色和TUNEL法检测各组海马CA1区神经细胞凋亡;用免疫组织化学法检测海马CA1区神经细胞中cPLA2蛋白表达;用ELISA法检测血清中TNF-α和前列腺素E2(PGE2)水平。结果与假手术组比较,模型组不同时间点凋亡细胞及cPLA2蛋白表达增强,且血清中TNF-α和PGE2水平也显著增高(P<0.01)。与模型组比较,治疗组能明显降低海马CA1区细胞凋亡数和cPLA2蛋白表达,同时也能降低血清中TNF-α和PGE2水平(P<0.01)。结论褪黑素对大鼠大脑中动脉缺血再灌注脑损伤有良好的保护作用:降低缺血再灌注后血清中TNF-α和PGE2水平,抑制缺血再灌注后海马CA1区cPLA2蛋白表达。     

酵母菌2号培养最佳条件的选择

成人特发性乳糖酶缺乏症的发生率极高，这些人进食牛奶后会出现胃肠胀气、腹痛、腹泄等对牛奶不耐受的消化不良症状。为解决这一问题，自１９８９年起，国内外不少学者是主张有产替代疗法，即将人工培养制备纯化的乳糖酶直接加入牛奶中以水解其中的乳糖来弥补成人乳糖酶的缺乏。     

肠系膜上动脉闭塞性休克过程中肺对血液抗凝物质及纤溶活力的影响

以犬(9只)肠系膜上动脉闭塞性休克为模型,测定了蛋白C活性、纤溶个原激活物总活力以及抗凝血酶Ⅲ活性。结果表明:正常犬出肺血蛋白C活性明显高于入肺血(P<0.05)、纤溶酶原激活物总活力也高于入肺血,而抗凝血酶Ⅲ活性明显低于入肺血(P<0.01)。正常及肠系膜上动脉闭塞性休克过程中,出肺血蛋白C活性在松夹后10分钟之前基本稳定,之后略微下降;纤溶酶原激活物总活力在松夹后30分钟时才开始下降,二者的变化呈显著正相关(r=0.8804,P<0.05)。入、出肺血抗凝血酶Ⅲ活性呈一定的波动性变化,尤以入肺血更为明显,且二者波动的方向相反。提示:1)正常肺血管内皮细胞参与抗凝物质蛋白C、纤溶活力以及抗凝血酶Ⅲ的调节;2)肠系膜上动脉闭塞性休克早期,肺对血液抗凝物质具有一定的调整作用;3)体内不同抗凝系统发挥作用的特征不尽相同,它们之间可能协同发挥作用。     

Risk factors for sleep disturbance in patients with cervical myelopathy and its clinical significance: a cross-sectional study

BACKGROUND CONTEXTSleep disturbance is highly prevalent in patients with spinal cord injury and is one of the most important clinical issues affecting their quality of life. However, it has not been properly measured or treated in patients with cervical myelopathy (CM), although most typical or atypical symptoms of CM are known to be risk factors for sleep disturbance. In addition, previous studies identified that the presence of sleep disturbance is unintentionally missed under the current evaluation process for degenerative spinal disease without direct investigation using validated tools for sleep. Therefore, studies about sleep disturbances in patients with CM are essential.PURPOSEThe purpose of this study was to investigate the prevalence of sleep disturbance in patients with CM using validated tools and to understand its mechanism by identifying high-risk patients.STUDY DESIGN/SETTINGCross-sectional study.PATIENT SAMPLEConsecutive patients diagnosed with CM.OUTCOME MEASURESPittsburgh sleep quality index.METHODSThis study was performed on patients diagnosed with CM. Sleep disturbance was determined using the Pittsburgh sleep quality index. Variables associated with sleep disturbance including demographics, lifestyle, medical history, and radiologic parameters were investigated. Independent risk factors related to sleep disturbance were identified using multivariate logistic regression analysis.RESULTSA total of 203 patients with CM were included in our study. Among them, 126 patients (62.1%) were men, and the mean age was 63.0 years. Despite male predominance, sleep disturbance was identified in 71.4% of patients (145 of 203). Multivariate analysis identified a worse depression scale score, a lower modified Japanese Orthopedic Association score, chronic shoulder joint pain, smaller spinal cord area, and decreased cervical range of motion as independent risk factors for sleep disturbance.CONCLUSIONSIn patients with CM, sleep disturbance was associated with a more severe type of myelopathy. Further studies including polysomnography and measurement of melatonin will be helpful to identify the mechanisms of the sleep disturbance in patients with CM and to improve their quality of life and clinical outcomes.     

Can Swimming Microalgal Cells be Vehicles for ZnO Nanoparticle Transportation and Thus Lead to Zn Diffusion?

The concentration of eco-toxic zinc oxide nanoparticles (nZnO) in aquatic ecosystems is increasing, and an effective method for their removal is needed. We hypothesize that microalgal cells may act as nZnO vehicles—if the nZnO concentration does not affect their swimming ability—enabling Zn diffusion and sedimentation. We conducted experiments using flasks connected via a U-type vessel; the first flask contained nZnO suspensions and second flask contained artificial seawater, respectively. We added microalgae to the first flask and illuminated the second. The microalgae appeared to promote sedimentation. However, only a few microalgal cells passed via phototaxis into the second flask, so the detection of nZnO or Zn ions in the second flask was not possible. Therefore, to confirm whether the microalgae affect Zn transportation, a more accurate method to detect nZnO or Zn ions at very low concentrations is needed.

     

Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China

BackgroundAlthough the efficacy of hepatitis B vaccines among hemodialysis patients has been documented, the long-term persistence of immunogenicity in this population remains largely unknown. We explored the long-term persistence of immunogenicity induced by different hepatitis B vaccine regimens in hemodialysis patients.MethodsIn initial study, we conducted a randomized, multicenter, double-blind, parallel-controlled trial among hemodialysis patients in 13 hospitals in Shanxi Province, China. A total of 352 hemodialysis patients were allocated to receive 3-dose 20 μg (IM20 group) and 3-dose 60 μg (IM60 group) recombinant hepatitis B vaccine at months 0, 1, and 6. Vaccine-induced immune responses were measured at month 7. In this study, the responders (anti-HBs ≥ 10 mIU/mL) were followed up at months 18, 24, 30, 36 and 42, respectively. We used the generalized log-rank test and generalized estimating equations (GEE) to analyze the long-term durability of responses and the kinetics of anti-HBs levels, respectively.ResultsA total of 284 patients were involved in the extended follow-up period. The duration of vaccine-induced response with 75% of patients maintained protective antibody were 12 months and 18 months in the IM20 group and IM60 group, respectively (P = 0.291). The long-term persistent immunogenicity induced by 3-dose 60 μg was more satisfactory than that by 3-dose 20 μg hepatitis B vaccine in patients with hemodialysis duration ≥ five years (P = 0.023). The peak anti-HBs levels in 100–1000 mIU/mL or ≥ 1000 mIU/mL were more likely to maintain long-term protective antibody compared to anti-HBs levels in 10–100 mIU/mL (P ＜ 0.05). The kinetic profile was similar between the two groups (P = 0.334).ConclusionHigh-dose 60 μg hepatitis B vaccine could lead a satisfactory long-term durability of immunogenicity among patients with hemodialysis duration of five years or more. Peak anti-HBs level after vaccination was associated with the long-term persistence of immunogenicity.